Noncardia Gastric Cancer Risk Higher in Hispanic and Asian Populations Edited by Shrabasti Bhattacharya July 21, 2026 ++ ++ ++ +

Noncardia Gastric Cancer Risk Higher in Hispanic and Asian Populations Edited by Shrabasti Bhattacharya https://www.medscape.com/viewarticle/noncardia-gastric-cancer-risk-higher-hispanic-and-asian-2026a1000on5?src= In the US, the incidence of noncardia gastric cancer was more than three times higher among Hispanic and non-Hispanic Asian or Pacific Islander populations than among non-Hispanic White populations. Incidence rates seen in non-Hispanic White adults aged 60-69 years occurred up to two decades earlier in several Asian groups. Blood Test Flags Gynaecologic Cancer Risk in NHS Trial Dr Sheena Meredith https://www.medscape.com/viewarticle/blood-test-flags-gynaecological-cancer-risk-nhs-trial-2026a1000omh?src= A blood test has correctly flagged more than 99% of gynaecologic cancers as elevated or high risk in the largest real-world evaluation of an AI-enabled cancer triage tool carried out in the NHS, according to a study published in Mayo Clinic Proceedings Digital Health. Focal Therapy Shows Favorable Long-Term Outcomes in Prostate Cancer Edited by Victoria Stern https://www.medscape.com/viewarticle/focal-therapy-shows-favorable-long-term-outcomes-prostate-2026a1000oma?src= July 21, 2026 Eur Urol. 2026; doi:10.1016/j.eururo.2026.05.007 A retrospective study provides the largest contemporary analysis of long-term outcomes of focal therapy in patients with nonmetastatic prostate cancer, reporting low 10-year cancer-specific mortality (0.13%) and metastasis rates (3.3%) among the nearly 3500 patients who received focal therapy using high-intensity focused ultrasound (HIFU) or cryotherapy. Use of Adjuvant Radiation Therapy Remains Stagnant for Localized Merkel Cell Edited by Gargi Mukherjee https://www.medscape.com/viewarticle/use-adjuvant-radiation-therapy-remains-stagnant-localized-2026a1000oig?src= July 20, 2026 J Am Acad Dermatol. 2026; Adjuvant radiation therapy (RT) use increased modestly among surgically treated patients with Merkel cell carcinoma (MCC) between 2000 and 2020, but rates did not increase for localized disease. doi:10.1016/j.jaad.2026.07.022 Adjuvant Chemo Tied to Longer Survival After Pelvic Exenteration Edited by Victoria Stern https://www.medscape.com/viewarticle/adjuvant-chemo-tied-longer-survival-after-pelvic-2026a1000oez?src= July 20, 2026 JAMA Netw Open. 2026;9(6):e2620335. doi:10.1001/jamanetworkopen.2026.20335 Adjuvant chemotherapy was associated with substantially longer median overall survival (28 vs 10 months) in patients undergoing pelvic exenteration for gynecologic cancers with pelvic lymph node metastasis. Chemotherapy was also associated with significantly longer median disease-free survival (DFS; 20 vs 7 months) and cancer-specific survival (28 vs 13 months). CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma Edited by Gargi Mukherjee https://www.medscape.com/viewarticle/csf-biomarker-panel-may-improve-diagnosis-cns-lymphoma-2026a1000ok8?src= July 21, 2026 Lancet Haematol. 2026;13(6):e376-e385. doi:10.1016/S2352-3026(26)00098-0 A cerebrospinal fluid (CSF) biomarker panel, combining MYD88 mutation testing with interleukin 10 (IL-10) and C-X-C motif chemokine ligand 13 (CXCL13) measurements, showed high specificity for CNS lymphoma and correctly identified more than half of the CNS lymphoma cases. With further validation, this panel could help reduce reliance on invasive brain biopsy in selected patients, the authors suggested. Glucose and A1c Mediate the Risk for Obesity-Related Pancreatic Cancer Edited by Gargi Mukherjee https://www.medscape.com/viewarticle/glucose-and-a1c-mediate-risk-obesity-related-pancreatic-2026a1000o64?src= Obesity increased the risk for pancreatic cancer by 20% per SD increase in BMI, with glucose and A1c mediating approximately 16% and 20% of this association, respectively.